An update from Ondine Biomedical, Inc. ( (GB:OBI) ) is now available.
Ondine Biomedical Inc., a non-UK issuer, has recently issued new shares, leading to a change in the holdings of M&G Plc, a major stakeholder based in London. This issuance resulted in M&G Plc’s voting rights in Ondine Biomedical decreasing from 10.299591% to 9.182066%, impacting the company’s shareholder structure.
More about Ondine Biomedical, Inc.
YTD Price Performance: 37.14%
Average Trading Volume: 525,860
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £48.48M
Find detailed analytics on OBI stock on TipRanks’ Stock Analysis page.